Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05NUP
|
|||
| Former ID |
DIB009410
|
|||
| Drug Name |
SBS-1000
|
|||
| Synonyms |
PrInsulin; Diabetes therapy, SemBioSys; Human insulin (safflower), SemBioSys; Plant-derived insulin (diabetes), SemBioSys; Safflower seed-derived human insulin (diabetes), SemBioSys
Click to Show/Hide
|
|||
| Indication | Diabetic complication [ICD-11: 5A2Y; ICD-9: 253.5, 588.1] | Phase 1 | [1] | |
| Company |
SemBioSys Genetics Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study. Clin Exp Immunol. 2009 Feb;155(2):156-65. | |||
| REF 2 | Synergistic antihyperglycemic effects between plant-derived oleanolic acid and insulin in streptozotocin-induced diabetic rats. Ren Fail. 2010;32(7):832-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.